Mato just raised pre-seed Read more
Podcast charts
Published by Improzo
You’re about to enter a new dimension — where the boundaries of life sciences, data and technology blur, and AI reshapes what’s possible.
On the charts
Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.
The Mato Topic Intelligence Platform does not report this podcast as charting in a published category in this snapshot.
From the feed
The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.
The way life sciences companies have commercialised products for years is being challenged from every direction. Changing customer expectations, growing market complexity, new technologies, and evolving healthcare ecosystems are all raising the same question: Is improving the current model enough, or is it time to rethink it altogether? In Season 2, Episode 5.2 of The Improzone, Jane Urban continues her conversation with Indraneel Mukherjee, Partner at Guidehouse, to explore what meaningful commercial transformation actually looks like. From reimagining commercial models and modernising workflows to the role of governance, organisational change, and AI-enabled execution, this episode examines why transformation isn't about adding another tool or another process. It's about redesigning how organisations make decisions, operate at scale, and prepare for what's next. Because lasting transformation doesn't happen by simply doing the same things faster. It begins by questioning what should change, what should stay, and having the confidence to build a better way forward. #LifeSciences #CommercialStrategy #CommercialTransformation #Pharma #DigitalTransformation #AI #Improzo
AI is changing the way life sciences organisations think about technology, talent, and transformation. But as the pace of innovation accelerates, one question is becoming harder to ignore: What should companies build themselves, what should they partner for, and what does the future workforce need to succeed in an AI-first world? In Season 2, Episode 5.1 of The Improzone, Jane Urban is joined by Indraneel Mukherjee, Partner at Guidehouse, for a thought-provoking conversation on how life sciences organisations can navigate the next wave of AI transformation. From the build vs. buy debate and AI talent strategies to workforce readiness, organisational change, and the importance of combining strategic thinking with execution, this episode explores the decisions that will shape the future of commercial organisations. Because succeeding with AI isn't just about adopting new technology. It's about building the right capabilities, making better decisions, and creating organisations that are ready for what's next. How do you see the balance between building AI capabilities in-house and partnering with experts evolving over the next few years? #ImprozonePodcast #LifeSciences #ArtificialIntelligence #CommercialStrategy #DigitalTransformation #Pharma #AITransformation #Improzo
Season 2 Miniseries Episode 4.3 is officially live. New Improzone Podcast Episode In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to explore what the future of CRM in life sciences could look like and why the next evolution of CRM is less about technology and more about creating value for the people who use it every day. Key takeaways: Why CRM must evolve from a compliance tool into a system that genuinely supports field teams How poor data quality and low adoption create a cycle that limits the value of both CRM and AI Where AI is already delivering impact today, from voice-enabled call reporting to next best actions Why earning trust through small, practical AI wins matters more than ambitious "slideware" promises The three priorities leaders should focus on: strong data foundations, accurate field models, and targeted automation Why CRM decisions should be treated as a commercial strategy, not just an IT implementation A thought-provoking conversation on putting the "relationship" back into customer relationship management and building systems that work better for both people and business outcomes. #ImprozonePodcast #CRM #LifeSciences #ArtificialIntelligence #PharmaTech #DigitalTransformation #CommercialOperations #CustomerExperience #Improzo
Season 2 Miniseries Episode 4.2 is officially live.New Improzone Podcast EpisodeIn this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to unpack the present-day realities of CRM transformation, where life sciences, data, and technology intersect, and where teams are now being forced to make some of their most critical platform decisions.Key takeaways:- Why CRM decisions today are no longer just about features, but about entire enterprise ecosystems- The real trade-offs between Veeva Vault CRM and Salesforce Life Sciences Cloud in pharma environments- How platform depth across clinical, regulatory, and commercial systems is reshaping migration complexity- The hidden cost layers from integrations to change management, that often define success or failure- How AI-driven narratives from both platforms are influencing (but not yet proving) real-world outcomes- Why early-stage biotech companies are increasingly locking into ecosystems like Veeva Basics from day oneA grounded, real-world conversation on what’s actually happening inside CRM decision rooms today, the pressure, the complexity, and the trade-offs that don’t always show up in presentations.#improzonepodcast #crm #lifesciences #digitaltransformation #customerexperience #pharmatech #aiinhealthcare #improzo
Season 2 Episode 4.1 is officially live. New Improzone Podcast Episode In this episode, Jane Urban sits down with Jason Harlander (Executive Director, Technology Management, Improzo) to explore the origins of CRM in life sciences and how early decisions continue to shape the industry today. Key takeaways: * How Salesforce started as a SaaS disruptor and built the foundation for modern CRM * Why Veeva’s vertical-first approach transformed pharma CRM adoption * The role of force.com in accelerating innovation without building from scratch * How early strategic decisions helped Veeva capture massive market share * What the Veeva Salesforce split means for the industry today A grounded conversation on where CRM really came from and why understanding its history is key to making better decisions moving forward.
New Improzone Podcast Episode Jane Urban sits down with Navdeep Singh (AWS Customer Success Leader) to explore Perception vs. Perspective: Rethinking AI Adoption in Biopharma, a conversation that goes beyond the hype to examine how AI is actually being adopted across life sciences organizations today. Key takeaways: • The gap between how AI is perceived and how it performs in real-world settings • Why adoption challenges are often operational, not technical • The importance of context, governance, and decision ownership in AI systems • Moving beyond pilots toward execution-focused AI strategies • Why human judgment continues to play a critical role alongside AI A grounded, practical conversation on what it really takes to make AI work in biopharma not just in theory, but in execution. #ImprozonePodcast #AIForLifeSciences #Biopharma #AIAdoption #AgenticAI #ImprozoThoughtLeadership
New Improzone Podcast Episode Jane Urban sits down with Stephen Gatchell (Ortecha) to explore how MDM and AI are evolving together — and why the “golden record” mindset no longer works at scale.Key takeaways:• MDM is shifting from rigid systems of truth to context-driven data philosophies• AI-enabled documentation, observability, and metadata enrichment are changing how data is mastered• Small language models and modular agents outperform one-size-fits-all AI• The real power is human + AI, not automation alone• Entry-level work is changing — but critical thinking and communication matter more than ever A practical, honest conversation about what’s actually working — and what’s next.#ImprozonePodcast #AIForLifeSciences #DataStrategy #MDM #AgenticAI #ImprozoThoughtLeadership
Most biotech companies are stuck in "pilot purgatory" with Generative AI. But moving from a fun experiment to a scalable, enterprise-grade solution requires more than just a software license, it demands a fundamental shift in how IT partners with Legal, QA, and Regulatory teams. In the Season 2 premiere of The Improzone , host Jane Urban sits down with Andrew Schwartz (Head of Global IT, KalVista Pharmaceuticals) to break down the roadmap for scaling AI across the enterprise . In this episode, we cover: Shadow IT vs. Enterprise Strategy: Why moving off personal ChatGPT accounts is the first step to security. The "Human-in-the-Loop": How to deploy Agentic AI that assists rather than replaces. Cross-Functional Governance: How to get Legal and QA to say "Yes" to innovation. If you are leading digital transformation in life sciences , this is your blueprint for 2026. #GenerativeAI #LifeSciences #PharmaAI #BiotechInnovation #EnterpriseAI #DigitalTransformation #KalVista #TheImprozone #AIgovernance #Improzo
We are LIVE with the finale of our mini-series! In Episode 4.4 - The AI Adoption Arc, we shift the focus outward to exploring Externally Facing AI Tools.While internal efficiencies are critical, the true competitive advantage in Life Sciences lies in how AI reshapes your customer touchpoints. From personalized HCP engagement to responsive patient support, we unpack how to deploy AI that builds trust rather than just cutting costs.Don’t leave the most visible part of your business in the analog age.#Improzo #LifeSciences #AIAdoption #PharmaTech #CustomerExperience #GenerativeAI #DigitalTransformation
In the latest episode of The Improzone Mini-Series 4.3, we explore the critical shift from legal compliance to technical verification. Key Insight: Treat your third-party AI like an "over-eager intern"—talented, capable, but lacking the judgment to represent your brand without supervision. In this episode, we unpack: - The Limits of Questionnaires: Why paper surveys fail to catch GenAI hallucinations. - Brand vs. Security: Why a secure bot can still be toxic. - Continuous Validation: Why a one-time pen test is already obsolete. Join Jane Urban and Nathan Trueblood for a masterclass in AI procurement safety. #ArtificialIntelligence #PharmaTech #DigitalHealth #RiskManagement #AIEthics #VendorManagement #TechLeadership #EnkryptAI #Improzo
In Part 2 of The AI Adoption Arc, we break down the critical shift to building proprietary LLM agents. Discover the severe security vulnerabilities introduced by prompt injection and data contamination in custom workflows. Learn how to implement use-case specific guardrails to achieve measurable, compliant scale. #AICapability #DigitalTransformation #LifeSciencesTech #ComplianceByDesign #AIStrategy #Improzo #ImprozonePodcast
How do life sciences organizations move from AI buzzwords to business impact? In this episode of The Improzone, discover how to start small, build trust, and make AI your co-pilot for smarter pharma decisions.Watch now and learn how real innovation begins. #Improzone #AIInPharma #Improzo #LifeSciencesAI #HealthcareInnovation #AIAdoption #DataDrivenDecisions
Here comes our 3rd podcast of the ImproZone! Join host Jane Urban and Indy Sawhney (AWS) as this episode speaks directly on the execution of Generative AI in Life Sciences . We dive into how #GenerativeAI is: Enhancing human performance in R&D and commercial roles. Enabling faster, smarter insights across global biopharma operations. Moving from AI strategy to an actionable execution plan . Listen now to unlock your next steps in #CommercialTransformation ! #LifeSciences #Biopharma #GenAI #DigitalTransformation #Execution #Improzo #Improzone
New Podcast Episode of The Improzone! Can AI and privacy coexist in pharma? In this episode, our host Jane Urban talks to Improzo's Abhishek Trigunait and Enkrypt AI's Nathan Trueblood about making responsible AI a reality. We're exploring the future of AI in Lifesciences, focusing on data privacy, compliance, and the power of strategic partnerships. Watch Now and secure the future of your AI strategy. To know more about us, visit www.improzo.com #AI #Lifesciences #Biotech #HealthTech #Podcast #Improzone #EnkryptAI #Innovation #Pharma #Improzo
You’re about to enter a new dimension—where AI doesn’t just sit in dashboards, it makes decisions. Improzo CEO Inderpreet Kambo joins host Jane Urban to talk about building modular, pharma-native AI agents that work where users already are—from Veeva to Salesforce. Why do most pharma AI programs fail? And how do you go from “insight” to actual impact? Step into The Improzone. 🎧 Listen now.
Ranking source
Apple Podcasts rankings via the Mato Topic Intelligence Platform.
Observed October 22, 2026.
Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.
Pairs with
Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.